Billionaire Paul Allen's foundation is funding a new type of evacuation "cocoon" to help fly sick medical workers from West Africa
If you can't beat them, avoid them.
The Pentagon commits to planning for higher temperatures, and retired generals line up to help
Mobile food startups are moving beyond delivery into food prep
Cities relax or abandon purchasing restrictions in a bid to avoid more serious downturn
Ministry of Supply’s Aviator jacket combines the structure of a tailored garment with the functionality of a windbreaker
The Department of Education may double the number of debt collectors who go after defaulted federal student loans
This year's must-have Silicon Valley office accessory: a $199 bear costume
King of Prussia, Pa.
Founders: Dr. Robert Lefkowitz and Dr. Howard Rockman
VC Investment over the last four quarters: $26.1 million
Trevena, founded in January 2008, is a drug discovery company developing pharmaceuticals that target what are known as G-protein coupled receptors. Such drugs make up more than 40% of marketed drugs today, according to Trevena. The company's drug discovery platform is based on research from Duke University Medical Center, including that of founder and National Medal of Science winner Robert Lefkowitz.
Key to startup success: "We've been able to generate the strong investor support for this idea [because] the technology and the opportunity here is very, very unique, and the possibility of unlocking new areas of biology is so significantly different from what's currently out there."